{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:46:37Z","timestamp":1792003597526,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T00:00:00Z","timestamp":1302220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1038\/eye.2011.75","type":"journal-article","created":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T13:11:18Z","timestamp":1302268278000},"page":"872-880","source":"Crossref","is-referenced-by-count":67,"title":["Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis"],"prefix":"10.1038","volume":"25","author":[{"given":"A","family":"Kheirkhah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M K","family":"Zavareh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Farzbod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mahbod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Behrouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,8]]},"reference":[{"issue":"1 Part 1","key":"BFeye201175_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0091-6749(05)80033-8","volume":"89","author":"L Bielory","year":"1992","unstructured":"Bielory L, Frohman LP . Allergic and immunologic disorders of the eye. J Allergy Clin Immunol 1992; 89 (1 Part 1): 1\u201315.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"BFeye201175_CR2","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S0161-6420(00)00092-0","volume":"107","author":"S Bonini","year":"2000","unstructured":"Bonini S, Bonini S, Lambiase A, Marchi S, Pasqualetti P, Zuccaro O et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term follow-up. Ophthalmology 2000; 107 (6): 1157\u20131163.","journal-title":"Ophthalmology"},{"issue":"2","key":"BFeye201175_CR3","first-page":"88","volume":"34","author":"KF Tabbara","year":"1999","unstructured":"Tabbara KF . Ocular complications of vernal keratoconjunctivitis. Can J Ophthalmol 1999; 34 (2): 88\u201392.","journal-title":"Can J Ophthalmol"},{"issue":"3","key":"BFeye201175_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/0002-9394(86)90819-6","volume":"101","author":"D BenEzra","year":"1986","unstructured":"BenEzra D, Pe\u2019er J, Brodsky M, Cohen E . Cyclosporine eye drops for the treatment of severe vernal keratoconjunctivitis. Am J Ophthalmol 1986; 101 (3): 278\u2013282.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"BFeye201175_CR5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0002-9394(14)77061-8","volume":"110","author":"AG Secchi","year":"1990","unstructured":"Secchi AG, Tognon MS, Leonardi A . Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol 1990; 110 (6): 641\u2013645.","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"BFeye201175_CR6","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/S0161-6420(91)32069-4","volume":"98","author":"JH Bleik","year":"1991","unstructured":"Bleik JH, Tabbara KF . Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology 1991; 98 (11): 1679\u20131684.","journal-title":"Ophthalmology"},{"issue":"6","key":"BFeye201175_CR7","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4049\/jimmunol.139.6.1797","volume":"139","author":"S Sawada","year":"1987","unstructured":"Sawada S, Suzuki G, Kawase Y, Takaku F . Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J Immunol 1987; 139 (6): 1797\u20131803.","journal-title":"J Immunol"},{"issue":"1 Part 3","key":"BFeye201175_CR8","first-page":"3156","volume":"21","author":"C Kobayashi","year":"1989","unstructured":"Kobayashi C, Kanai A, Nakajima A, Okumura K . Suppression of corneal graft rejection in rabbits by a new immunosuppressive agent, FK-506. Transplant Proc 1989; 21 (1 Part 3): 3156\u20133158.","journal-title":"Transplant Proc"},{"issue":"8","key":"BFeye201175_CR9","first-page":"2477","volume":"34","author":"M Nishi","year":"1993","unstructured":"Nishi M, Herbort CP, Matsubara M, Morishita M, Nishimura M, Nieda M et al. Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat. Invest Ophthalmol Vis Sci 1993; 34 (8): 2477\u20132486.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"BFeye201175_CR10","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/S0161-6420(01)00759-X","volume":"108","author":"CM Sloper","year":"2001","unstructured":"Sloper CM, Powell RJ, Dua HS . Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts. Ophthalmology 2001; 108 (10): 1838\u20131844.","journal-title":"Ophthalmology"},{"issue":"9","key":"BFeye201175_CR11","first-page":"550","volume":"39","author":"J Chen","year":"2003","unstructured":"Chen J, Zhou Q, Zeng J, Xu JT, Zhao SB, Wang YP . The study of FK506 eye drops preventing and treating immune rejection on limbal allograft transplantation. Zhonghua Yan Ke Za Zhi 2003; 39 (9): 550\u2013554 (in Chinese).","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"3\u20134","key":"BFeye201175_CR12","first-page":"152","volume":"40","author":"FN Yal\u00e7indag","year":"2008","unstructured":"Yal\u00e7indag FN, Incel O, Ozdemir O . Effectiveness of tacrolimus in high-risk limbal allo-graft transplantation. Ann Ophthalmol (Skokie) 2008; 40 (3\u20134): 152\u2013156.","journal-title":"Ann Ophthalmol (Skokie)"},{"issue":"8","key":"BFeye201175_CR13","first-page":"1265","volume":"29","author":"H Kawashima","year":"1988","unstructured":"Kawashima H, Fujino Y, Mochizuki M . Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats. Invest Ophthalmol Vis Sci 1988; 29 (8): 1265\u20131271.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl","key":"BFeye201175_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/02713689208999516","volume":"11","author":"M Mochizuki","year":"1992","unstructured":"Mochizuki M, Ikeda E, Shirao M, Fujito S, Yoshimura K, Shimada N . Preclinical and clinical study of FK506 in uveitis. Curr Eye Res 1992; 11 (Suppl): 87\u201395.","journal-title":"Curr Eye Res"},{"issue":"4","key":"BFeye201175_CR15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0161-6420(99)90156-2","volume":"106","author":"CM Sloper","year":"1999","unstructured":"Sloper CM, Powell RJ, Dua HS . Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine. Ophthalmology 1999; 106 (4): 723\u2013728.","journal-title":"Ophthalmology"},{"issue":"5","key":"BFeye201175_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s004170050252","volume":"237","author":"H Iwamoto","year":"1999","unstructured":"Iwamoto H, Yoshida H, Yoshida O, Fukushima A, Ueno H . Inhibitory effects of FK506 on the development of experimental allergic\/immune-mediated blepharoconjunctivitis in Lewis rats by systemic but not by topical administration. Graefes Arch Clin Exp Ophthalmol 1999; 237 (5): 407\u2013414.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"BFeye201175_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1055\/s-2001-18665","volume":"218","author":"K Mayer","year":"2001","unstructured":"Mayer K, Reinhard T, Reis A, B\u00f6hringer D, Sundmacher R . FK 506 ointment 0.1%\u2014A new therapeutic option for atopic blepharitis. Clinical trial with 14 patients. Klin Monbl Augenheilkd 2001; 218 (11): 733\u2013736. German.","journal-title":"Klin Monbl Augenheilkd"},{"issue":"3","key":"BFeye201175_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0002-9394(02)01982-7","volume":"135","author":"SM Rikkers","year":"2003","unstructured":"Rikkers SM, Holland GN, Drayton GE, Michel FK, Torres MF, Takahashi S . Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol 2003; 135 (3): 297\u2013302.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"BFeye201175_CR19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1600-0420.2006.00699.x","volume":"84","author":"HM Virtanen","year":"2006","unstructured":"Virtanen HM, Reitamo S, Kari M, Kari O . Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study. Acta Ophthalmol Scand 2006; 84 (5): 693\u2013695.","journal-title":"Acta Ophthalmol Scand"},{"issue":"4","key":"BFeye201175_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1468-3083.2008.02933.x","volume":"23","author":"H Zribi","year":"2009","unstructured":"Zribi H, Descamps V, Hoang-Xuan T, Crickx B, Doan S . Dramatic improvement of atopic keratoconjunctivitis after topical treatment with tacrolimus ointment restricted to the eyelids. J Eur Acad Dermatol Venereol 2009; 23 (4): 489\u2013490.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"BFeye201175_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/ICO.0b013e318159afbb","volume":"27","author":"GD Kymionis","year":"2008","unstructured":"Kymionis GD, Goldman D, Ide T, Yoo SH . Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis. Cornea 2008; 27 (2): 228\u2013229.","journal-title":"Cornea"},{"issue":"2","key":"BFeye201175_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jaci.2003.10.065","volume":"113","author":"P Vichyanond","year":"2004","unstructured":"Vichyanond P, Tantimongkolsuk C, Dumrongkigchaiporn P, Jirapongsananuruk O, Visitsunthorn N, Kosrirukvongs P . Vernal keratoconjunctivitis: result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment. J Allergy Clin Immunol 2004; 113 (2): 355\u2013358.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"BFeye201175_CR23","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.ophtha.2007.07.025","volume":"115","author":"D Miyazaki","year":"2008","unstructured":"Miyazaki D, Tominaga T, Kakimaru-Hasegawa A, Nagata Y, Hasegawa J, Inoue Y . Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases. Ophthalmology 2008; 115 (6): 988\u2013992.e5.","journal-title":"Ophthalmology"},{"issue":"2","key":"BFeye201175_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1089\/jop.2009.0087","volume":"26","author":"Y Ohashi","year":"2010","unstructured":"Ohashi Y, Ebihara N, Fujishima H, Fukushima A, Kumagai N, Nakagawa Y et al. A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis. J Ocul Pharmacol Ther 2010; 26 (2): 165\u2013174.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"10","key":"BFeye201175_CR25","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/01.ico.0000240091.11854.14","volume":"25","author":"T Stumpf","year":"2006","unstructured":"Stumpf T, Luqmani N, Sumich P, Cook S, Tole D . Systemic tacrolimus in the treatment of severe atopic keratoconjunctivitis. Cornea 2006; 25 (10): 1147\u20131149.","journal-title":"Cornea"},{"issue":"8","key":"BFeye201175_CR26","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1097\/ICO.0b013e318172fbb1","volume":"27","author":"F Anzaar","year":"2008","unstructured":"Anzaar F, Gallagher MJ, Bhat P, Arif M, Farooqui S, Foster CS . Use of systemic T-lymphocyte signal transduction inhibitors in the treatment of atopic keratoconjunctivitis. Cornea 2008; 27 (8): 884\u2013888.","journal-title":"Cornea"},{"issue":"7","key":"BFeye201175_CR27","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/sj.eye.6702367","volume":"21","author":"E Nivenius","year":"2007","unstructured":"Nivenius E, van der Ploeg I, Jung K, Chryssanthou E, van Hage M, Montan PG . Tacrolimus ointment vssteroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis. Eye (Lond) 2007; 21 (7): 968\u2013975.","journal-title":"Eye (Lond)"},{"issue":"11","key":"BFeye201175_CR28","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1046\/j.1365-2222.2003.01698.x","volume":"33","author":"T Sengoku","year":"2003","unstructured":"Sengoku T, Sakuma S, Satoh S, Kishi S, Ogawa T, Ohkubo Y et al. Effects of FK506 eye drops on late and delayed-type responses in ocular allergy models. Clin Exp Allergy 2003; 33 (11): 1555\u20131560.","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"BFeye201175_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/01.ico.0000151507.49565.6e","volume":"24","author":"MA Joseph","year":"2005","unstructured":"Joseph MA, Kaufman HE, Insler M . Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders. Cornea 2005; 24 (4): 417\u2013420.","journal-title":"Cornea"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye201175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye201175","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye201175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T05:54:42Z","timestamp":1686030882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye201175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,8]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["BFeye201175"],"URL":"https:\/\/doi.org\/10.1038\/eye.2011.75","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,8]]}}}